DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV1D-8; IGLV3-21; IGKV3-11; IGLV3-19; IGLV2-14; IGKV1-9; IGKV2D-29; IGLV4-69; IGLV2-23; IGKV3-20; IGKV2-24; IGLV2-8; IGKV4-1; IGKV1-16; IGLV6-57; IGLV2-11; IGKV1-27; IGKV1-6; IGKV1-17; IGLV1-40; IGLV3-1; IGLV1-44; IGKV1-5; IGLV3-25; IGLV8-61; IGLV2-18; IGKV2-30; IGLV1-47; IGKV3-15; IGLV3-10;	GO:0002377~immunoglobulin production	30	107	28.0373831775701	0	0	0	0	0	0	0
up	HP; HPR; JCHAIN; IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; APOA1; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; SAA1; IGLC2; IGLC3; FOLR2; IGHV1-2; FCGR2B; IGLV3-21; CLEC9A; FCGR1B; STAB1; CD207;	GO:0006898~receptor-mediated endocytosis	47	160	29.375	0	0	0	0	0	0	0
up	IGHV3-11; IGHV4-39; IGHV3-74; IGLL5; IGHG2; IGHV3-30; IGHV1-2; TRDC; IGHV1-46; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHG4; IGHV3-15; IGHV1-69-2; IGHV3-21; IGLC3; IGHV3-23; IGHG3; IGHV3-7; IGHV2-5; IGHD; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV3-48; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	32	99	32.3232323232323	0	0	0	0	0	0	0
up	IGKV1-17; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	41	92	44.5652173913043	0	0	0	0	0	0	0
up	IGHG3; IGHV1-69-2; IGHG4; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV3-73; IGHV3-23; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV1-46; IGHV5-51; IGHV1-3; IGHV4-34; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	32	98	32.6530612244898	0	0	0	0	0	0	0
up	KRT33A; KRT14; KRT6B; IVL; KRT16; KRT4; FLG; SPRR1B; SPRR2E; SPRR2D; SPRR1A; SPRR2B; SPRR2A; KRT20; KRT6C; KRT17; TCHH; KRT32; KRT31; KRT40; SPINK6; RPTN; DSG4; SPRR2F; LCE3D; SPRR2G; SPRR3; KLK12; KLK13; KLK5;	GO:0070268~cornification	30	113	26.5486725663717	0	0	0	0	0	0	0
down	ISLR; MPDZ; ITGBL1; LAMC1; COL6A1; COL6A2; COL6A3; CCL2; COL5A1; COL8A1; THBS2; COL15A1; CXCL12; CCL11; MFAP4; CDH11; CDH15; SRPX; DPT; SPOCK1; NID2; LAMA4; DDR2; SVEP1; FEZ1; NTM; ITGA11; CNTN6; LOXL2; EMILIN1; PCDHA3; PCDHA7; PCDHB5; PCDHB10; PCDH18;	GO:0007155~cell adhesion	35	454	7.70925110132159	0	0	0	0	0	0	0
down	TNFRSF11B; MATN3; COL1A1; COL3A1; COL5A2; DCN; COL1A2; FGF2; LAMC1; COL11A1; COL6A1; COL6A2; COL6A3; ELN; PDGFRA; COL5A1; BGN; FBLN1; COL8A1; FBN1; COMP; LUM; ITGA8; MFAP2; LOXL1; FOXF1; FOXF2; NID2; LAMA4; DDR2; CCDC80; PXDN; ITGA11; MMP2; COL15A1; MMP23B; COL22A1;	GO:0030198~extracellular matrix organization	37	230	16.0869565217391	0	0	0	0	0	0	0
down	FGF10; AGT; PENK; COL1A1; NR2F2; TACR3; PTGFR; GGT5;	GO:0032355~response to estradiol	8	103	7.76699029126214	0.00012321980437834	0.00393967601723744	0.269604931979829	0.277860658873178	0.213909580400815	0.269604931979829	0.032692781441995
down	APOE; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.0001239627532017	0.00393967601723744	0.271106541252119	0.279536008469835	0.214827451298547	0.271106541252119	0.032692781441995
down	ANGPT1; CCBE1; RSPO3; LOXL2; VEGFD;	GO:0002040~sprouting angiogenesis	5	32	15.625	0.00012448458314784	0.00393967601723744	0.272123298761186	0.280712734998387	0.215453455184429	0.271998814178038	0.032692781441995
down	PDGFRA; DLX2; SIX1; TWIST1; SIX2;	GO:0048701~embryonic cranial skeleton morphogenesis	5	32	15.625	0.00012448458314784	0.00393967601723744	0.272123298761186	0.280712734998387	0.215453455184429	0.271998814178038	0.032692781441995
down	IGF1; HMGA2; HAND2; TWIST1;	GO:2000679~positive regulation of transcription regulatory region DNA binding	4	16	25	0.00012579009899826	0.00393967601723744	0.274725576212218	0.283656673241096	0.216987920772013	0.274725576212218	0.032692781441995
down	TRPA1; PENK; GIP; UCHL1; CCL2; EDNRB;	GO:0019233~sensory perception of pain	6	53	11.3207547169811	0.00013265069493395	0.00409763448049411	0.289576467040825	0.29912731707607	0.224664252979187	0.289576467040825	0.0340035748913977
down	APOE; GRIA1; NFATC4; NPAS4; SHANK1;	GO:0007616~long-term memory	5	33	15.1515151515152	0.00014178658332597	0.00420695717631678	0.309236538233953	0.319728745400075	0.23394786248786	0.309094751650627	0.034910772078563
down	AGT; IGF1; MMP2; FGF2; HTR1B;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	5	33	15.1515151515152	0.00014178658332597	0.00420695717631678	0.309236538233953	0.319728745400075	0.23394786248786	0.309094751650627	0.034910772078563
down	PENK; COL1A1; COL6A1; IGFBP3; SOX8; TWIST1; TMEM119; ITGA11;	GO:0001649~osteoblast differentiation	8	106	7.54716981132075	0.00014834977011069	0.00428090991806046	0.323254149071192	0.334528731599605	0.240634372614556	0.323254149071192	0.0355244572679756
down	GPR37; FZD7; KCNK2; AGT; PENK; APOE; CHRM2; GIP; SCT; ADRB3; LHCGR; EDNRB; HTR1B; TACR3; PTGER1; ADRA1A; ADRA1B; PTGFR; CXCL12; GPR17; GPR176; KISS1; ARHGEF25; TMEM145; FZD8; PDE11A; CCL8; OR5AS1; CCL11; MRGPRF; CCL2; CCL7;	GO:0007186~G protein-coupled receptor signaling pathway	32	1152	2.77777777777778	0.00015268650081246	0.00428090991806046	0.332551198769538	0.344308059332097	0.245061833803998	0.332551198769538	0.0355244572679756
down	COL6A1; MATN3; COL6A3; COL6A2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	4	17	23.5294117647059	0.00015375810140272	0.00428090991806046	0.334577628652326	0.346724518663141	0.24616672034576	0.334452019873305	0.0355244572679756
down	SCX; TCF21; HAND2; TWIST1; COLEC10;	GO:0032502~developmental process	5	34	14.7058823529412	0.00016086898370848	0.00431856616979324	0.349568301598536	0.362759558262632	0.253188102185316	0.349407432614828	0.0358369417470134
down	COL3A1; COL5A2; COL5A1; COMP; COL1A1;	GO:0043588~skin development	5	34	14.7058823529412	0.00016086898370848	0.00431856616979324	0.349568301598536	0.362759558262632	0.253188102185316	0.349407432614828	0.0358369417470134
down	PALM3; FGF10; PENK; DCN; ELANE; PTGER1; PTGFR; LOXL1; GGT5;	GO:0032496~response to lipopolysaccharide	9	138	6.52173913043478	0.00016489712055145	0.00437462360992389	0.357991648717209	0.371843006843531	0.256909713819167	0.357991648717209	0.036302125592175
down	FGF18; COL1A1; MMP2;	GO:0001957~intramembranous ossification	3	6	50	0.00018410676244795	0.00465924419766601	0.399327567749615	0.415160749320139	0.275055503097245	0.398959354224719	0.0386640047487941
down	CLEC3B; HPN; MELTF;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.00018410676244795	0.00465924419766601	0.399327567749615	0.415160749320139	0.275055503097245	0.398959354224719	0.0386640047487941
down	INHA; INHBA; FOXL2;	GO:0046881~positive regulation of follicle-stimulating hormone secretion	3	6	50	0.00018410676244795	0.00465924419766601	0.399327567749615	0.415160749320139	0.275055503097245	0.398959354224719	0.0386640047487941
down	UCHL1; COMP; FLNC; WFIKKN2;	GO:0048747~muscle fiber development	4	18	22.2222222222222	0.0001859565311707	0.00465924419766601	0.402781846515748	0.419331977789941	0.276870898682699	0.402781846515748	0.0386640047487941
down	KCNK2; COL3A1; DCN; GDF5; PIEZO2; COL1A1;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.00019126636111388	0.00468810482947619	0.414091671811559	0.431305644311809	0.281838766094469	0.413900405450446	0.0389035001600715
down	FGF10; GLI2; PDGFRA; HAND2; DLX2; LHX8;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.00019126636111388	0.00468810482947619	0.414091671811559	0.431305644311809	0.281838766094469	0.413900405450446	0.0389035001600715
down	FGF18; GDF5; GDF6; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	4	19	21.0526315789474	0.00022274656038567	0.00540100530827639	0.481800810114222	0.502293493669704	0.305482418221985	0.481800810114222	0.0448193925942041
down	TCF21; CRLF1; SIX1; FOXC2; SALL1;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00023001553897916	0.00551792596168108	0.497293595272959	0.518685040398021	0.309846692827123	0.497293595272959	0.0457896402366727
down	AGT; IGF1; ADRA1A; HAND2;	GO:0010613~positive regulation of cardiac muscle hypertrophy	4	20	20	0.00026449634495517	0.00614885832859719	0.571576601448141	0.596439257873927	0.330794647072015	0.57104760875823	0.0510253331936618
down	GREM1; GLI2; GDF5; ADAMTS12;	GO:0032331~negative regulation of chondrocyte differentiation	4	20	20	0.00026449634495517	0.00614885832859719	0.571576601448141	0.596439257873927	0.330794647072015	0.57104760875823	0.0510253331936618
down	CCL11; CCL7; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	4	20	20	0.00026449634495517	0.00614885832859719	0.571576601448141	0.596439257873927	0.330794647072015	0.57104760875823	0.0510253331936618
down	COL6A3; TFPI2; ITIH3; SPOCK1; ITIH5; WFIKKN2; AGT; TIMP3; SERPINA3;	GO:0010951~negative regulation of endopeptidase activity	9	148	6.08108108108108	0.00026965572325554	0.00620483322389038	0.581917050785469	0.608073655941257	0.333833785390366	0.581917050785469	0.0514898320534797
down	GREM1; SP9; GDF5; TBX5; TBX4;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.00028730778798724	0.00654423294859837	0.619722898688488	0.647879061911238	0.344122501173708	0.619722898688488	0.0543062872576141
up	SAA1; CCL26; XCL2; CCL18; CCL24; CCL14; XCL1; CCL19;	GO:0048247~lymphocyte chemotaxis	8	33	24.2424242424242	0.00029452774928706	0.0179201727456849	0.564315167634018	0.573445527861917	0.561369890141147	0.564315167634018	0.146076600908556
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00035072019684356	0.0206924916137705	0.671629176955433	0.682852223254427	0.63199779471211	0.671629176955433	0.16867520654879
down	LECT2; FGF2; CCL2; CXCL12; CCL11; CCL8; CCL7; RARRES2;	GO:0006935~chemotaxis	8	122	6.55737704918033	0.00036397120457276	0.00815106228821595	0.784721917058884	0.820755066311588	0.37889402396025	0.784721917058884	0.0676403076656015
down	FGF10; AGT; IGF1; MIF; IL11; FGF7; ANGPT1;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	7	92	7.60869565217391	0.00036508083862962	0.00815106228821595	0.786749207246848	0.823257291109811	0.379318991336183	0.786749207246848	0.0676403076656015
down	APOE; CRB1; SVEP1; NOX4;	GO:0010467~gene expression	4	23	17.3913043478261	0.00042327422624466	0.00935768019785996	0.911732683331004	0.954483380181715	0.405578545268102	0.911732683331004	0.0776532365032499
down	FOXS1; COL1A1; COL1A2; COL5A1; FOXF1;	GO:0001568~blood vessel development	5	43	11.6279069767442	0.00043365972538833	0.00940291039183362	0.933669388761087	0.977902680750697	0.409949957835851	0.933235729035698	0.0780285721500621
down	CDH11; CDH15; CDH18; CADM3; CDH10;	GO:0034332~adherens junction organization	5	43	11.6279069767442	0.00043365972538833	0.00940291039183362	0.933669388761087	0.977902680750697	0.409949957835851	0.933235729035698	0.0780285721500621
down	ATP10A; PALM; HPN; CCL2; CCL11; CCL7; CDC42EP5; BVES; FERMT2;	GO:0008360~regulation of cell shape	9	159	5.66037735849057	0.00044318930069087	0.00951801783864681	0.953300185786065	0.999391873057915	0.413931215694195	0.953300185786065	0.0789837731829755
down	COL3A1; THY1; FBLN1; ITGA8; FERMT2; ITGA11; ITGBL1;	GO:0007229~integrin-mediated signaling pathway	7	96	7.29166666666667	0.00046428992997493	0.00986404427234459	0.998223349446115	1	0.422461356293655	0.997102327989186	0.081855219088816
down	FBN1; MFAP2; FOXL2;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.0004680499942975	0.00986404427234459	1	1	0.423962502127692	0.997102327989186	0.081855219088816
down	COL11A1; PDGFRA; SIX1; OSR2; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	5	44	11.3636363636364	0.00047770522248502	0.00997430811762715	1	1	0.427822373034966	0.997102327989186	0.0827702262566654
down	FGF10; ISL1; NKX6-1; FOXF1;	GO:0031016~pancreas development	4	24	16.6666666666667	0.00048865734969771	0.0100174756688032	1	1	0.43225398732038	0.997102327989186	0.0831284453868201
down	HPN; GLI2; SIX1; CTHRC1;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.00048865734969771	0.0100174756688032	1	1	0.43225398732038	0.997102327989186	0.0831284453868201
down	MIF; PRELP; TBX2; NOX4;	GO:0007569~cell aging	4	25	16	0.00056091926661927	0.0112935084484506	1	1	0.460500161902183	0.997102327989186	0.093717402599369
down	FGF2; WNT2; TBX2; TBX5;	GO:0060045~positive regulation of cardiac muscle cell proliferation	4	25	16	0.00056091926661927	0.0112935084484506	1	1	0.460500161902183	0.997102327989186	0.093717402599369
down	COMP; HMGA2; DDR2;	GO:0035988~chondrocyte proliferation	3	10	30	0.00060246860772905	0.0119172518458686	1	1	0.474142794282767	0.997102327989186	0.0988934390243068
down	IGFBP3; IGFBP4; NKX6-1;	GO:0044342~type B pancreatic cell proliferation	3	10	30	0.00060246860772905	0.0119172518458686	1	1	0.474142794282767	0.997102327989186	0.0988934390243068
down	GREM1; HTRA3; RBPMS2; HTRA1; CHRDL1;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00063015521855025	0.012250000153714	1	1	0.483329052628045	0.997102327989186	0.101654698492341
down	PITX3; GLI2; EPHA5; EN1; ISL2;	GO:0048666~neuron development	5	47	10.6382978723404	0.00063015521855025	0.012250000153714	1	1	0.483329052628045	0.997102327989186	0.101654698492341
down	FZD7; LAMC1; ITGA8; BVES; FERMT2;	GO:0034446~substrate adhesion-dependent cell spreading	5	48	10.4166666666667	0.0006882657709808	0.0132652932783052	1	1	0.502504517607638	0.997102327989186	0.110079948710021
down	EDNRB; SOX8; NGF; GDNF;	GO:0007422~peripheral nervous system development	4	27	14.8148148148148	0.00072765985646994	0.0136739414694977	1	1	0.515822609522736	0.997102327989186	0.113471051415642
down	FGF10; GLI2; ISL1; SALL1;	GO:0021983~pituitary gland development	4	27	14.8148148148148	0.00072765985646994	0.0136739414694977	1	1	0.515822609522736	0.997102327989186	0.113471051415642
down	CDH18; CDH11; CDH15; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	4	27	14.8148148148148	0.00072765985646994	0.0136739414694977	1	1	0.515822609522736	0.997102327989186	0.113471051415642
down	INHBA; HMGA2; ITGA8;	GO:0048333~mesodermal cell differentiation	3	11	27.2727272727273	0.00075922675593875	0.0141492259061314	1	1	0.523107234841804	0.997102327989186	0.117415124517506
down	SIX1; NR2F2; NR2F1; SPOCK1; SIX2;	GO:0048856~anatomical structure development	5	50	10	0.00081639334125904	0.0148457176324548	1	1	0.536370425207194	0.997102327989186	0.123194851501457
up	CLDN5; CLDN1; CLDN8; CLDN17; CLDN18; CLDN10;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	6	21	28.5714285714286	0.00081960436305306	0.0463757590507182	1	1	0.99999992997781	0.99999992997781	0.378032809327375
down	SLIT3; ELN; TWIST1; EMILIN1;	GO:0003180~aortic valve morphogenesis	4	28	14.2857142857143	0.00082293334991434	0.0148457176324548	1	1	0.537814266116369	0.997102327989186	0.123194851501457
down	ADRB3; ADRA1B; ADRA1A; SHANK1;	GO:0007610~behavior	4	28	14.2857142857143	0.00082293334991434	0.0148457176324548	1	1	0.537814266116369	0.997102327989186	0.123194851501457
down	PENK; COL3A1; CXCL12; CCL11;	GO:0009314~response to radiation	4	28	14.2857142857143	0.00082293334991434	0.0148457176324548	1	1	0.537814266116369	0.997102327989186	0.123194851501457
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00085748707027522	0.0463757590507182	1	1	0.99999992997781	0.99999992997781	0.378032809327375
down	FGF18; COL1A1; TMEM119; SCX;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.00092667412394353	0.0162443287683828	1	1	0.56009686537122	0.997102327989186	0.134801005913437
down	SOX8; NKX6-1; GPR17; TRPC4;	GO:0048709~oligodendrocyte differentiation	4	29	13.7931034482759	0.00092667412394353	0.0162443287683828	1	1	0.56009686537122	0.997102327989186	0.134801005913437
down	SOX8; TMEM119; CTHRC1;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.00093969336807808	0.0162443287683828	1	1	0.562876327478774	0.997102327989186	0.134801005913437
down	EDNRB; GDNF; SOX8;	GO:0048484~enteric nervous system development	3	12	25	0.00093969336807808	0.0162443287683828	1	1	0.562876327478774	0.997102327989186	0.134801005913437
down	FGF10; FLRT2; FGF18; FGF2; FGF5; FGF7;	GO:0008543~fibroblast growth factor receptor signaling pathway	6	79	7.59493670886076	0.00096298412997752	0.0164509788871161	1	1	0.567272254901885	0.997102327989186	0.136515859403204
up	JCHAIN; IGKV3-20; IGHA2; LTF; CTSG; H2BFS; RNASE6;	GO:0019731~antibacterial humoral response	7	31	22.5806451612903	0.00100665052538385	0.0515775940242723	1	1	0.99999992997781	0.99999992997781	0.420435657905216
down	CDX1; SFRP4; OSR2; PAPPA2;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.00103928166833089	0.0173598530524901	1	1	0.582030276667602	0.997102327989186	0.144058008634979
down	FGF10; AGT; IGF1; CCL11;	GO:0070371~ERK1 and ERK2 cascade	4	30	13.3333333333333	0.00103928166833089	0.0173598530524901	1	1	0.582030276667602	0.997102327989186	0.144058008634979
down	NGF; GLI2; GDF5; FOXG1; NKX6-1; GDF6;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.00108741163011117	0.0178986366854065	1	1	0.591551926780475	0.997102327989186	0.148529019824323
down	CCL2; ADAMTS12; PTGIS; CCL8; CCL11; CCL7;	GO:0071347~cellular response to interleukin-1	6	81	7.40740740740741	0.00108741163011117	0.0178986366854065	1	1	0.591551926780475	0.997102327989186	0.148529019824323
down	AGT; ANGPT1; CCBE1; ATOH8; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	5	54	9.25925925925926	0.00112492814946585	0.0183819780945326	1	1	0.598520219076702	0.997102327989186	0.15253995244449
down	FGF10; FOXF1; NFATC4;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.00114517103641154	0.018439474063488	1	1	0.602413481784068	0.997102327989186	0.153017073694722
down	INHBA; TWIST1; OSR2;	GO:0061029~eyelid development in camera-type eye	3	13	23.0769230769231	0.00114517103641154	0.018439474063488	1	1	0.602413481784068	0.997102327989186	0.153017073694722
down	GLI2; BMP5; SIX1; TBX5;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.0011611553512263	0.018439474063488	1	1	0.605653234234775	0.997102327989186	0.153017073694722
down	COL1A1; MMP2; PDGFRA; SCX;	GO:0060325~face morphogenesis	4	31	12.9032258064516	0.0011611553512263	0.018439474063488	1	1	0.605653234234775	0.997102327989186	0.153017073694722
down	GREM1; NR2F2; COMP; SALL1;	GO:0060173~limb development	4	32	12.5	0.00129269392564857	0.0202887568499117	1	1	0.628249247865205	0.997102327989186	0.168363055876116
down	AGT; PDGFRA; EDNRB; ADRA1A; KISS1; PTGER1; ADRA1B; PTGFR;	GO:0007204~positive regulation of cytosolic calcium ion concentration	8	150	5.33333333333333	0.00130653040649564	0.0203188004596391	1	1	0.63067893242284	0.997102327989186	0.168612368043475
up	IL2RA; SCGB1A1; CTLA4; VTCN1; LILRB2; LILRB1; FOXJ1; CD80;	GO:0042130~negative regulation of T cell proliferation	8	43	18.6046511627907	0.0013454773642233	0.0671703699523787	1	1	0.99999992997781	0.99999992997781	0.547540443033753
down	AGT; NPPB; EDNRB;	GO:0035815~positive regulation of renal sodium excretion	3	14	21.4285714285714	0.00137689787564832	0.0211218007454895	1	1	0.642860063222768	0.997102327989186	0.175275939547402
down	FGF10; VEGFD; CXCL12;	GO:0050930~induction of positive chemotaxis	3	14	21.4285714285714	0.00137689787564832	0.0211218007454895	1	1	0.642860063222768	0.997102327989186	0.175275939547402
down	COL11A1; ATP6V1B1; ITGA8; FOXG1; SIX1;	GO:0042472~inner ear morphogenesis	5	57	8.7719298245614	0.00140745199016434	0.0212785220772063	1	1	0.647775718515299	0.997102327989186	0.176576466855407
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00140858222384987	0.0685627397458927	1	1	0.99999992997781	0.99999992997781	0.558890369707493
down	FXYD1; CHRM2; TBX2; HSPB7;	GO:0008016~regulation of heart contraction	4	33	12.1212121212121	0.00143429505797577	0.0212785220772063	1	1	0.652604251378973	0.997102327989186	0.176576466855407
down	EN1; TWIST1; OSR2; TBX5;	GO:0035115~embryonic forelimb morphogenesis	4	33	12.1212121212121	0.00143429505797577	0.0212785220772063	1	1	0.652604251378973	0.997102327989186	0.176576466855407
down	COL1A2; INHBA; TWIST1; OSR2;	GO:0042476~odontogenesis	4	33	12.1212121212121	0.00143429505797577	0.0212785220772063	1	1	0.652604251378973	0.997102327989186	0.176576466855407
down	CCL8; CCL2; CCL7; CCL11;	GO:0048247~lymphocyte chemotaxis	4	33	12.1212121212121	0.00143429505797577	0.0212785220772063	1	1	0.652604251378973	0.997102327989186	0.176576466855407
up	CXCL13; S100A7; CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	5	16	31.25	0.0016168647787228	0.0749532315279357	1	1	0.99999992997781	0.99999992997781	0.61098257500611
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	5	16	31.25	0.0016168647787228	0.0749532315279357	1	1	0.99999992997781	0.99999992997781	0.61098257500611
down	GREM1; NOX4; CDH18; CDH15; CDH11; CDH10;	GO:0000902~cell morphogenesis	6	88	6.81818181818182	0.00162204644495056	0.0234824241516556	1	1	0.680039010414973	0.997102327989186	0.194865201392024
down	FGF5; CRB1; KLF15;	GO:0010001~glial cell differentiation	3	15	20	0.00163604934007222	0.0234824241516556	1	1	0.682232574810116	0.997102327989186	0.194865201392024
down	PDGFRA; ACTC1; FHOD3;	GO:0055003~cardiac myofibril assembly	3	15	20	0.00163604934007222	0.0234824241516556	1	1	0.682232574810116	0.997102327989186	0.194865201392024
down	APOE; INHBA; ISL2; HIF3A; DLX2; BARX1; SCX; SP9; FOXC2; FOXL2; EN1; NR2F1; TWIST1; KLF15; FOXS1; TCF21; CDX1; FOXD1; HAND2; NPAS4; NR2F2;	GO:0006357~regulation of transcription by RNA polymerase II	21	747	2.81124497991968	0.00170542303451804	0.0234824241516556	1	1	0.69095934488879	0.997102327989186	0.194865201392024
down	AGT; LHCGR; EDNRB; ADRA1A; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.00173905314116474	0.0234824241516556	1	1	0.695621256465895	0.997102327989186	0.194865201392024
down	FGF18; ELANE; FGF2; MIF; NOX4;	GO:0043406~positive regulation of MAP kinase activity	5	60	8.33333333333333	0.00173905314116474	0.0234824241516556	1	1	0.695621256465895	0.997102327989186	0.194865201392024
down	HPN; AR; GDF5; ISL1; RGN;	GO:0050680~negative regulation of epithelial cell proliferation	5	60	8.33333333333333	0.00173905314116474	0.0234824241516556	1	1	0.695621256465895	0.997102327989186	0.194865201392024
up	IL2RA; IL5RA; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00176193826517879	0.0762331956067355	1	1	0.99999992997781	0.99999992997781	0.621416224534469
up	UGT1A9; UGT1A1; CYP2C18; UGT1A3; UGT1A7; UGT1A8;	GO:0042573~retinoic acid metabolic process	6	25	24	0.00176193826517879	0.0762331956067355	1	1	0.99999992997781	0.99999992997781	0.621416224534469
up	CLDN1; KRT16; FLG; FLG2; ABCA12; HRNR;	GO:0061436~establishment of skin barrier	6	25	24	0.00176193826517879	0.0762331956067355	1	1	0.99999992997781	0.99999992997781	0.621416224534469
down	RSPO4; RSPO1; RSPO3; SALL1;	GO:0030177~positive regulation of Wnt signaling pathway	4	36	11.1111111111111	0.00192342487036656	0.0253686181271273	1	1	0.719618000439125	0.997102327989186	0.210517485267018
down	AR; GDNF; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	4	36	11.1111111111111	0.00192342487036656	0.0253686181271273	1	1	0.719618000439125	0.997102327989186	0.210517485267018
down	MT1H; MT1L; MT1G;	GO:0010273~detoxification of copper ion	3	16	18.75	0.00192373999988416	0.0253686181271273	1	1	0.719618000439125	0.997102327989186	0.210517485267018
down	ISL1; SIX1; ISL2;	GO:0048665~neuron fate specification	3	16	18.75	0.00192373999988416	0.0253686181271273	1	1	0.719618000439125	0.997102327989186	0.210517485267018
down	EDNRB; THPO; ANGPT1; RSPO1; TMEM119; KNDC1; RARRES2; VEGFD;	GO:0001934~positive regulation of protein phosphorylation	8	161	4.96894409937888	0.00199704342320151	0.0261821681355779	1	1	0.72913741276384	0.997102327989186	0.217268601983732
down	COL8A1; FOXF1; CCDC80; EMILIN1;	GO:0010811~positive regulation of cell-substrate adhesion	4	37	10.8108108108108	0.00210921586150903	0.0273681056867676	1	1	0.741482389115391	0.997102327989186	0.227109918121217
down	APOE; ELANE; ISL1; FOXF1; PTGIS; FNDC4;	GO:0050728~negative regulation of inflammatory response	6	93	6.45161290322581	0.00211177400864637	0.0273681056867676	1	1	0.741482389115391	0.997102327989186	0.227109918121217
down	PENK; SOD3; CXCL12; CYGB; NOX4; LOXL2; MMP2; VEGFD;	GO:0001666~response to hypoxia	8	163	4.9079754601227	0.00214877105099442	0.0276884498285282	1	1	0.745623554695065	0.997102327989186	0.22976824356904
down	TBX4; TBX5; SOX8;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00224102527647452	0.0282319106058661	1	1	0.755225518171912	0.997102327989186	0.234278067305324
down	FGF18; COL11A1; COMP;	GO:0002063~chondrocyte development	3	17	17.6470588235294	0.00224102527647452	0.0282319106058661	1	1	0.755225518171912	0.997102327989186	0.234278067305324
down	FZD7; COL1A1; SPOCK1;	GO:0010812~negative regulation of cell-substrate adhesion	3	17	17.6470588235294	0.00224102527647452	0.0282319106058661	1	1	0.755225518171912	0.997102327989186	0.234278067305324
down	C8B; C7; C6;	GO:0019835~cytolysis	3	17	17.6470588235294	0.00224102527647452	0.0282319106058661	1	1	0.755225518171912	0.997102327989186	0.234278067305324
down	SCT; EPHA5; DLX2; CDK5R2; FEZ1;	GO:0021766~hippocampus development	5	64	7.8125	0.00226589598981097	0.0283866414279097	1	1	0.758302412326165	0.997102327989186	0.235562076682054
up	CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	4	10	40	0.00234697504156622	0.0988716489838551	1	1	0.99999992997781	0.99999992997781	0.8059539723613
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00238673215317986	0.0988716489838551	1	1	0.99999992997781	0.99999992997781	0.8059539723613
down	CCL2; ADRB3; LHCGR; HTR1B; CHRM2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	5	65	7.69230769230769	0.00241394291275188	0.0287585053122922	1	1	0.774147537359847	0.997102327989186	0.238647930606361
down	ELANE; MMP2; LAMC1; HTRA1; ADAMTS5;	GO:0022617~extracellular matrix disassembly	5	66	7.57575757575758	0.00256888966439539	0.0287585053122922	1	1	0.789972574349313	0.997102327989186	0.238647930606361
down	ISL1; TBX2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	3	18	16.6666666666667	0.00258890313897797	0.0287585053122922	1	1	0.792204360527259	0.997102327989186	0.238647930606361
down	MT1G; MT1H; MT1L;	GO:0045926~negative regulation of growth	3	18	16.6666666666667	0.00258890313897797	0.0287585053122922	1	1	0.792204360527259	0.997102327989186	0.238647930606361
down	GRIK2; KISS1; RIMS4;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.00258890313897797	0.0287585053122922	1	1	0.792204360527259	0.997102327989186	0.238647930606361
down	BMP5; ISL1; SIX1;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.00258890313897797	0.0287585053122922	1	1	0.792204360527259	0.997102327989186	0.238647930606361
down	STC2; MMP2; FBLN1; PTGIS;	GO:0007566~embryo implantation	4	40	10	0.00274023208087715	0.0301425528896486	1	1	0.805628231777881	0.997102327989186	0.250133231619403
down	HOXC11; GLI2; NR2F2; HOXC8; BARX1; HOXC9;	GO:0009952~anterior/posterior pattern specification	6	99	6.06060606060606	0.00283791610116102	0.0310655379034859	1	1	0.814481921033213	0.997102327989186	0.257792477506525
down	DLX2; OSR2; CDX1;	GO:0009790~embryo development	3	19	15.7894736842105	0.00296831576126277	0.0318740573411788	1	1	0.821738479026297	0.997102327989186	0.264501848823467
down	COMP; TWIST1; DDR2;	GO:0030500~regulation of bone mineralization	3	19	15.7894736842105	0.00296831576126277	0.0318740573411788	1	1	0.821738479026297	0.997102327989186	0.264501848823467
down	PDGFRA; BMP5; LHCGR;	GO:0030539~male genitalia development	3	19	15.7894736842105	0.00296831576126277	0.0318740573411788	1	1	0.821738479026297	0.997102327989186	0.264501848823467
down	AGT; APOE; EDNRB;	GO:0042311~vasodilation	3	19	15.7894736842105	0.00296831576126277	0.0318740573411788	1	1	0.821738479026297	0.997102327989186	0.264501848823467
up	S100A8; S100A9; SELE; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	4	11	36.3636363636364	0.00309296371971257	0.125458340880841	1	1	0.99999992997781	0.99999992997781	1
down	ADRA1A; SFRP4; FOXC2; TIMP3;	GO:0009725~response to hormone	4	42	9.52380952380952	0.00322605345527927	0.0343148610455412	1	1	0.832368669940295	0.997102327989186	0.284756474254694
down	COL1A1; ISL1; TWIST1; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	4	42	9.52380952380952	0.00322605345527927	0.0343148610455412	1	1	0.832368669940295	0.997102327989186	0.284756474254694
down	RIMS4; POPDC3; BVES; GABRR3; GABRA2; PIEZO2;	GO:0042391~regulation of membrane potential	6	102	5.88235294117647	0.00326417392931921	0.0345573343221353	1	1	0.834315042924549	0.997102327989186	0.286768600582476
down	SIX1; OSR2; SIX2;	GO:0042474~middle ear morphogenesis	3	20	15	0.00338015114138046	0.0352416121641688	1	1	0.839077042847187	0.997102327989186	0.292446972569747
down	CDH15; CDH11; CDH18; CDH10;	GO:0007043~cell-cell junction assembly	4	43	9.30232558139535	0.0034896170521943	0.0352416121641688	1	1	0.844174057839761	0.997102327989186	0.292446972569747
down	PALM; APOE; THY1; CCL2; CCL11; CCL7; KISS1;	GO:0007010~cytoskeleton organization	7	139	5.03597122302158	0.00349313876602086	0.0352416121641688	1	1	0.844174057839761	0.997102327989186	0.292446972569747
up	JCHAIN; PIGR; IGKC; IGHG3; IGHA2; LTF; POTEE;	GO:0001895~retina homeostasis	7	40	17.5	0.00359429901950925	0.141167574999116	1	1	0.99999992997781	0.99999992997781	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00369776390598608	0.141167574999116	1	1	0.99999992997781	0.99999992997781	1
up	LTF; CLDN18; LILRB1;	GO:2001205~negative regulation of osteoclast development	3	5	60	0.00369776390598608	0.141167574999116	1	1	0.99999992997781	0.99999992997781	1
down	EDNRB; GDNF; SOX8; ISL1;	GO:0001755~neural crest cell migration	4	44	9.09090909090909	0.00376743135478153	0.0372612180045278	1	1	0.853569070270362	0.997102327989186	0.309206353810474
down	CCL2; CCL7; CCL11; CCL8;	GO:0002548~monocyte chemotaxis	4	44	9.09090909090909	0.00376743135478153	0.0372612180045278	1	1	0.853569070270362	0.997102327989186	0.309206353810474
down	FZD7; SFRP4; FZD8;	GO:0035567~non-canonical Wnt signaling pathway	3	21	14.2857142857143	0.0038252446837429	0.0373416742936807	1	1	0.855313500451668	0.997102327989186	0.309874007664598
down	VEGFD; PITX3; EN1;	GO:0071542~dopaminergic neuron differentiation	3	21	14.2857142857143	0.0038252446837429	0.0373416742936807	1	1	0.855313500451668	0.997102327989186	0.309874007664598
down	ADRA1A; ADRA1B; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	3	21	14.2857142857143	0.0038252446837429	0.0373416742936807	1	1	0.855313500451668	0.997102327989186	0.309874007664598
up	DEFB4A; LTF; S100A8; S100A9; CTSG; S100A7; RNASE6; PGLYRP3;	GO:0019730~antimicrobial humoral response	8	52	15.3846153846154	0.00385667066205442	0.14370688965998	1	1	0.99999992997781	0.99999992997781	1
down	FGF2; WNT2; CXCL12; CCL11; VEGFD;	GO:0001938~positive regulation of endothelial cell proliferation	5	73	6.84931506849315	0.00386210824576949	0.0375390262681474	1	1	0.856506739152075	0.997102327989186	0.311511701967418
up	CTSG; CPA3; CMA1; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.00398570726329683	0.14370688965998	1	1	0.99999992997781	0.99999992997781	1
up	TRPM2; GATA1; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	4	12	33.3333333333333	0.00398570726329683	0.14370688965998	1	1	0.99999992997781	0.99999992997781	1
down	APOE; DCN; NR2F2;	GO:0010596~negative regulation of endothelial cell migration	3	22	13.6363636363636	0.00430438074466455	0.0414802503385408	1	1	0.869484910422239	0.997102327989186	0.344217329684911
down	FBN1; ITGA11; ITGBL1;	GO:0033627~cell adhesion mediated by integrin	3	22	13.6363636363636	0.00430438074466455	0.0414802503385408	1	1	0.869484910422239	0.997102327989186	0.344217329684911
down	ELN; ISL1; TBX2; SIX1;	GO:0003151~outflow tract morphogenesis	4	46	8.69565217391304	0.00436722697377423	0.0417292238383936	1	1	0.871485394367771	0.997102327989186	0.346283397092465
down	TRPA1; GIP; EDNRB; LUM;	GO:0014070~response to organic cyclic compound	4	46	8.69565217391304	0.00436722697377423	0.0417292238383936	1	1	0.871485394367771	0.997102327989186	0.346283397092465
up	CYP2C9; CYP2C19; CYP4A11; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	5	21	23.8095238095238	0.004378566299158	0.155001246990193	1	1	0.99999992997781	0.99999992997781	1
down	NR2F2; CXCL12; NKX6-1; SPOCK1; CDK5R2; TWIST1;	GO:0001764~neuron migration	6	109	5.5045871559633	0.00444244048352227	0.0419671771188164	1	1	0.87383370830469	0.997102327989186	0.348258014943332
down	CCL8; CCL11; PF4V1; CCL7; CCL2;	GO:0030593~neutrophil chemotaxis	5	76	6.57894736842105	0.00453814718231804	0.0419671771188164	1	1	0.876267936166131	0.997102327989186	0.348258014943332
down	TRABD2B; NFATC4; SFRP4; BARX1;	GO:0030178~negative regulation of Wnt signaling pathway	4	47	8.51063829787234	0.00468990183323359	0.0419671771188164	1	1	0.88141370898715	0.997102327989186	0.348258014943332
down	STC2; COL1A1; GIP; CXCL12;	GO:0043434~response to peptide hormone	4	47	8.51063829787234	0.00468990183323359	0.0419671771188164	1	1	0.88141370898715	0.997102327989186	0.348258014943332
down	VEGFD; FGF2; FGF5; FGF7;	GO:0051781~positive regulation of cell division	4	47	8.51063829787234	0.00468990183323359	0.0419671771188164	1	1	0.88141370898715	0.997102327989186	0.348258014943332
down	APOE; COMP; FOXC2;	GO:0048844~artery morphogenesis	3	23	13.0434782608696	0.00481829414235047	0.0428822227914256	1	1	0.885066984929347	0.997102327989186	0.355851377456687
down	STC2; KCNK2; TWIST1; PTGIS; FMN2; HILPDA;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.00483019272240448	0.0428822227914256	1	1	0.885066984929347	0.997102327989186	0.355851377456687
down	GIP; GDNF; CXCL12; EN1;	GO:0008344~adult locomotory behavior	4	48	8.33333333333333	0.00502821405114462	0.0444651870012985	1	1	0.890917163296241	0.997102327989186	0.368987356841145
down	GREM1; ANGPT1; SFRP4;	GO:0002092~positive regulation of receptor internalization	3	24	12.5	0.00536767163177476	0.0469151144560159	1	1	0.90176883413816	0.997102327989186	0.389317694278887
down	HPN; BMP5; TBX5;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.00536767163177476	0.0469151144560159	1	1	0.90176883413816	0.997102327989186	0.389317694278887
down	APOE; EDNRB; NPPB;	GO:0019934~cGMP-mediated signaling	3	24	12.5	0.00536767163177476	0.0469151144560159	1	1	0.90176883413816	0.997102327989186	0.389317694278887
down	THY1; ITGA8; FOXF1; CDH10; CDH11; CDH15; CDH18;	GO:0098609~cell-cell adhesion	7	152	4.60526315789474	0.00555057261286795	0.0483264140618426	1	1	0.906604955036323	0.997102327989186	0.401029141961537
down	SCT; NPAS4; FGF14; RIMS4;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.00575307194092489	0.0497056598727419	1	1	0.913032953866699	0.997102327989186	0.412474596271289
down	CHRM2; HTR1B; ADRA1A; RIMS4;	GO:2000300~regulation of synaptic vesicle exocytosis	4	50	8	0.00575307194092489	0.0497056598727419	1	1	0.913032953866699	0.997102327989186	0.412474596271289
up	APOA1; ABRA; GPR55; GPR174; GPR65; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.00584176950794457	0.203105807713716	1	1	0.99999992997781	0.99999992997781	1
down	AGT; HILPDA; IL33;	GO:0001819~positive regulation of cytokine production	3	25	12	0.00595315334566648	0.0499046869683194	1	1	0.91854560566363	0.997102327989186	0.414126191303033
down	COL11A1; ISL1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.00595315334566648	0.0499046869683194	1	1	0.91854560566363	0.997102327989186	0.414126191303033
down	MT1G; MT1H; MT1L;	GO:0071294~cellular response to zinc ion	3	25	12	0.00595315334566648	0.0499046869683194	1	1	0.91854560566363	0.997102327989186	0.414126191303033
down	FGF10; COL3A1; DCN; FGF2; PDGFRA;	GO:0042060~wound healing	5	82	6.09756097560976	0.00613549512153133	0.0510933275111096	1	1	0.924422730306639	0.997102327989186	0.423989937790945
down	MIF; ISL1; NFATC4; TWIST1;	GO:0032760~positive regulation of tumor necrosis factor production	4	51	7.84313725490196	0.00614026241929522	0.0510933275111096	1	1	0.924422730306639	0.997102327989186	0.423989937790945
up	GCNT3; FABP1; ADRA2A; KCNQ1;	GO:0050892~intestinal absorption	4	14	28.5714285714286	0.00626054257781739	0.210159937913973	1	1	0.99999992997781	0.99999992997781	1
down	FZD7; AR; MIF;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.00657533420090362	0.0543127422089291	1	1	0.93742521845489	0.997102327989186	0.450705744021317
down	PITX3; PENK; TACR3;	GO:0043278~response to morphine	3	26	11.5384615384615	0.00657533420090362	0.0543127422089291	1	1	0.93742521845489	0.997102327989186	0.450705744021317
down	CCL11; FHOD3; PDLIM3; XIRP1; MYO7B; ACTC1;	GO:0007015~actin filament organization	6	121	4.95867768595041	0.00715075070201554	0.0583234338104775	1	1	0.949250721298145	0.997102327989186	0.483987837113989
down	FGF10; FGF7; ANGPT1;	GO:0034394~protein localization to cell surface	3	27	11.1111111111111	0.00723476527335509	0.0583234338104775	1	1	0.949899559795273	0.997102327989186	0.483987837113989
up	SPI1; LY6D; FLT3;	GO:0030098~lymphocyte differentiation	3	7	42.8571428571429	0.00743122776508476	0.239079606529767	1	1	0.99999992997781	0.99999992997781	1
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.00743122776508476	0.239079606529767	1	1	0.99999992997781	0.99999992997781	1
up	DEFB4A; LTF; S100A12; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	6	35	17.1428571428571	0.00749042424155921	0.239079606529767	1	1	0.99999992997781	0.99999992997781	1
up	MUC6; MUC13; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	4	15	26.6666666666667	0.00766548023715041	0.240720806802127	1	1	0.99999992997781	0.99999992997781	1
down	AGT; IGF1; DCN; PDGFRA; ANGPT1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	5	87	5.74712643678161	0.00773901479546302	0.0610191551180738	1	1	0.955503686991705	0.997102327989186	0.506357856159254
down	FGF10; GLI2; FGF7;	GO:0031069~hair follicle morphogenesis	3	28	10.7142857142857	0.00793195513943357	0.0621061070813288	1	1	0.957815389460234	0.997102327989186	0.515377755972631
down	AGT; RCVRN; CACNA2D1;	GO:0051924~regulation of calcium ion transport	3	28	10.7142857142857	0.00793195513943357	0.0621061070813288	1	1	0.957815389460234	0.997102327989186	0.515377755972631
down	COL1A1; CCL2; ADAMTS12; CCL8; CCL7; CCL11;	GO:0071356~cellular response to tumor necrosis factor	6	125	4.8	0.00827320248210428	0.0645538809589798	1	1	0.961101205547576	0.997102327989186	0.535690222289996
down	COMP; LTBP2; C1QTNF5; RAB3B;	GO:0009306~protein secretion	4	56	7.14285714285714	0.00833612625412705	0.0645978168489914	1	1	0.961961776427594	0.997102327989186	0.536054817359064
down	FGF10; FGF7; SYDE1; NRK;	GO:0031532~actin cytoskeleton reorganization	4	56	7.14285714285714	0.00833612625412705	0.0645978168489914	1	1	0.961961776427594	0.997102327989186	0.536054817359064
down	AGT; DCN; NPPB; THBS2; EMILIN1;	GO:0016525~negative regulation of angiogenesis	5	89	5.61797752808989	0.0084549406204959	0.0652941476000625	1	1	0.963733048530156	0.997102327989186	0.541833208515216
down	FXYD1; ATP10A; ATP6V1B1; GRIA1; GRIK2; ANO4; GABRA2; GABRR3;	GO:0034220~ion transmembrane transport	8	208	3.84615384615385	0.00863926424791339	0.0658115533025714	1	1	0.965574470022918	0.997102327989186	0.54612681831332
down	FGF10; NGF; IGF1;	GO:0046579~positive regulation of Ras protein signal transduction	3	29	10.3448275862069	0.00866737118664684	0.0658115533025714	1	1	0.965574470022918	0.997102327989186	0.54612681831332
down	MT1G; MT1L; MT1H;	GO:0071280~cellular response to copper ion	3	29	10.3448275862069	0.00866737118664684	0.0658115533025714	1	1	0.965574470022918	0.997102327989186	0.54612681831332
down	BMP5; LUM; DLX2; CHRDL2;	GO:0051216~cartilage development	4	58	6.89655172413793	0.00934117706982329	0.0682386192743819	1	1	0.972636517343564	0.997102327989186	0.566267443332873
down	MT1H; MT1G; MT1L;	GO:0006882~cellular zinc ion homeostasis	3	30	10	0.00944144089295218	0.0682386192743819	1	1	0.973732165238165	0.997102327989186	0.566267443332873
down	THY1; GRIK2; TMEFF1;	GO:0043113~receptor clustering	3	30	10	0.00944144089295218	0.0682386192743819	1	1	0.973732165238165	0.997102327989186	0.566267443332873
down	NGF; IGF1; ISL1;	GO:0043388~positive regulation of DNA binding	3	30	10	0.00944144089295218	0.0682386192743819	1	1	0.973732165238165	0.997102327989186	0.566267443332873
down	HMGA2; HAND2; WFIKKN2;	GO:0043392~negative regulation of DNA binding	3	30	10	0.00944144089295218	0.0682386192743819	1	1	0.973732165238165	0.997102327989186	0.566267443332873
down	IL11; ANGPT1; FGF21;	GO:2000352~negative regulation of endothelial cell apoptotic process	3	30	10	0.00944144089295218	0.0682386192743819	1	1	0.973732165238165	0.997102327989186	0.566267443332873
down	C8B; C7; C6; MASP1; COLEC10;	GO:0006956~complement activation	5	92	5.43478260869565	0.0096127807754216	0.0692550180465678	1	1	0.97599570154789	0.997102327989186	0.574701868593122
down	GPR37; PALM; HTR1B; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	4	59	6.77966101694915	0.00987194869640162	0.0702247454586298	1	1	0.978360969826592	0.997102327989186	0.582748998916058
down	FGF10; LEFTY1; FOXF1; ARMC4;	GO:0007368~determination of left/right symmetry	4	59	6.77966101694915	0.00987194869640162	0.0702247454586298	1	1	0.978360969826592	0.997102327989186	0.582748998916058
down	UCHL1; CERS1; HTR1B; FGF21;	GO:0035690~cellular response to drug	4	59	6.77966101694915	0.00987194869640162	0.0702247454586298	1	1	0.978360969826592	0.997102327989186	0.582748998916058
down	ZNF536; FOXG1; ISL1; ISL2;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.00987194869640162	0.0702247454586298	1	1	0.978360969826592	0.997102327989186	0.582748998916058
up	APOA4; AADAC; APOA1;	GO:0010898~positive regulation of triglyceride catabolic process	3	8	37.5	0.00989638052563357	0.275003992645761	1	1	0.99999992997781	0.99999992997781	1
up	C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	3	8	37.5	0.00989638052563357	0.275003992645761	1	1	0.99999992997781	0.99999992997781	1
up	SELE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.00989638052563357	0.275003992645761	1	1	0.99999992997781	0.99999992997781	1
down	FZD7; WNT2; HOXC8; FZD8; EN1; LHX8;	GO:0030182~neuron differentiation	6	131	4.58015267175572	0.0101861327155615	0.0722318530616072	1	1	0.982115145641043	0.997102327989186	0.599404665500722
down	APOE; NR2F2; ATOH8;	GO:0001937~negative regulation of endothelial cell proliferation	3	31	9.67741935483871	0.0102545530760048	0.0724890820889992	1	1	0.983425426611577	0.997102327989186	0.601539240104387
down	IGF1; DDR2; TMEM119; CTHRC1;	GO:0045669~positive regulation of osteoblast differentiation	4	60	6.66666666666667	0.0104218939710055	0.0730332677600359	1	1	0.984766904748076	0.997102327989186	0.606055079256954
up	C1QA; IL13; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.0108544902264793	0.283384877757916	1	1	0.99999992997781	0.99999992997781	1
down	AGT; COL1A2; NPPB; EDNRB;	GO:0008217~regulation of blood pressure	4	61	6.55737704918033	0.0109912605827456	0.0751069473154281	1	1	0.986204531701819	0.997102327989186	0.623263182712301
down	APOE; NR2F1; SPOCK1; ZNF365;	GO:0010977~negative regulation of neuron projection development	4	61	6.55737704918033	0.0109912605827456	0.0751069473154281	1	1	0.986204531701819	0.997102327989186	0.623263182712301
up	TRPM2; CCR2; CCR5; CCL19;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.011061762049102	0.283384877757916	1	1	0.99999992997781	0.99999992997781	1
down	AR; NR2F1; NR2F2;	GO:0030522~intracellular receptor signaling pathway	3	32	9.375	0.0111070591126919	0.075668937459578	1	1	0.986456435796762	0.997102327989186	0.627926769483106
down	CHRM2; ADRB3; ADRA1B; ADRA1A;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	4	62	6.45161290322581	0.0115802885976424	0.0786552734568782	1	1	0.987248134380869	0.997102327989186	0.652708408796828
down	GABRR3; FXYD1; GABRA2; ANO4; SLC26A10;	GO:1902476~chloride transmembrane transport	5	97	5.15463917525773	0.0117768762679631	0.0797503182710413	1	1	0.987808116306212	0.997102327989186	0.661795465859893
down	FGF10; TCF21; BARX1;	GO:0048536~spleen development	3	33	9.09090909090909	0.011999274129687	0.0810130633606116	1	1	0.988098477304538	0.997102327989186	0.672274157267422
down	ADH1B; APOE; RARRES2; GPC6;	GO:0001523~retinoid metabolic process	4	63	6.34920634920635	0.0121892104076143	0.0811079139012301	1	1	0.988396097327823	0.997102327989186	0.673061259552109
down	TRPA1; AGT; INHA; INHBA; CCL2; MIF; NPPB; EDNRB; GFRA1;	GO:0007166~cell surface receptor signaling pathway	9	268	3.35820895522388	0.0123752627870518	0.0811079139012301	1	1	0.989014231222337	0.997102327989186	0.673061259552109
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0127808937700724	0.31499240721938	1	1	0.99999992997781	0.99999992997781	1
up	IGHD; SAA1; HMGB1P1;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0127808937700724	0.31499240721938	1	1	0.99999992997781	0.99999992997781	1
down	TBX5; TBX4; TBX2;	GO:0001708~cell fate specification	3	34	8.82352941176471	0.0129314781653329	0.0840359748208234	1	1	0.990003245453559	0.997102327989186	0.697359312304232
up	CTSV; CTSG; MMP7; CMA1; MMP12; KLK7; TPSAB1; KLK5;	GO:0022617~extracellular matrix disassembly	8	66	12.1212121212121	0.013490248728904	0.3253455983019	1	1	0.99999992997781	0.99999992997781	1
down	F10; COL1A1; IGF1; PDGFRA; CCL11; CCL7; FOXF1; CXCL12;	GO:0030335~positive regulation of cell migration	8	226	3.53982300884956	0.0135070252852439	0.0875239713167388	1	1	0.991074677537384	0.997102327989186	0.72630390231937
down	PITX3; HTR1B; TACR3;	GO:0042220~response to cocaine	3	35	8.57142857142857	0.0139039173042954	0.0895809529176747	1	1	0.991839986168687	0.997102327989186	0.743373440427419
down	GRIA1; FGF14; GABRA2;	GO:0060078~regulation of postsynaptic membrane potential	3	35	8.57142857142857	0.0139039173042954	0.0895809529176747	1	1	0.991839986168687	0.997102327989186	0.743373440427419
up	XCL1; CD1B; CD1C; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	5	29	17.2413793103448	0.0139849033645429	0.332056181106892	1	1	0.99999992997781	0.99999992997781	1
down	VEGFD; IGF1; UCHL1; THPO; LMNTD1; SIX2;	GO:0008283~cell population proliferation	6	142	4.22535211267606	0.014474107882146	0.0901632963376773	1	1	0.993073617992279	0.997102327989186	0.748205925654892
down	CRLF1; COL1A2; MMP2; FGF2; CCL2; IL11; CCL11; TWIST1; IL1RAPL2;	GO:0019221~cytokine-mediated signaling pathway	9	278	3.23741007194245	0.0152617215084985	0.0948076639164299	1	1	0.994422902799334	0.997102327989186	0.786746479122768
down	CHRM2; CXCL12; CCL11; HMGA2; CCL8;	GO:0009615~response to virus	5	104	4.80769230769231	0.0153299009923942	0.0949695789501342	1	1	0.994901220693899	0.997102327989186	0.788090105549384
down	AOX1; NOX4; NDUFA4L2; LOXL2;	GO:0022900~electron transport chain	4	68	5.88235294117647	0.01553981813631	0.0957439614682488	1	1	0.994901220693899	0.997102327989186	0.794516197011335
down	HTRA3; WFIKKN2; HTRA1; EMILIN1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	4	68	5.88235294117647	0.01553981813631	0.0957439614682488	1	1	0.994901220693899	0.997102327989186	0.794516197011335
down	DCN; HTRA1; ETNK2;	GO:0001890~placenta development	3	37	8.10810810810811	0.0159703220737843	0.096925137727457	1	1	0.995747601700198	0.997102327989186	0.804318002316596
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0160947373333875	0.34589994128603	1	1	0.99999992997781	0.99999992997781	1
down	FOXS1; HAND2; TWIST1; SFRP4;	GO:0043433~negative regulation of DNA-binding transcription factor activity	4	69	5.79710144927536	0.016272548712279	0.096925137727457	1	1	0.996006708544253	0.997102327989186	0.804318002316596
down	IL11; HMGA2; SOX8; GDF6;	GO:0045444~fat cell differentiation	4	70	5.71428571428571	0.0170265822516	0.098922154108186	1	1	0.996837637388978	0.997102327989186	0.820889928481489
down	FZD7; WNT2; FZD8; SFRP4;	GO:0060070~canonical Wnt signaling pathway	4	70	5.71428571428571	0.0170265822516	0.098922154108186	1	1	0.996837637388978	0.997102327989186	0.820889928481489
down	INHA; INHBA; FOXL2;	GO:0001541~ovarian follicle development	3	38	7.89473684210526	0.0170646199326316	0.098922154108186	1	1	0.996837637388978	0.997102327989186	0.820889928481489
down	FLRT2; LEFTY1; COL5A1;	GO:0003007~heart morphogenesis	3	38	7.89473684210526	0.0170646199326316	0.098922154108186	1	1	0.996837637388978	0.997102327989186	0.820889928481489
down	IGF1; CCL2; TMEM100;	GO:0043491~protein kinase B signaling	3	38	7.89473684210526	0.0170646199326316	0.098922154108186	1	1	0.996837637388978	0.997102327989186	0.820889928481489
down	IGF1; FGF21; KLF15;	GO:0046326~positive regulation of glucose import	3	38	7.89473684210526	0.0170646199326316	0.098922154108186	1	1	0.996837637388978	0.997102327989186	0.820889928481489
up	CCL24; CCL18; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	4	20	20	0.0177511133249997	0.36001476712265	1	1	0.99999992997781	0.99999992997781	1
down	CDH11; GRIK2; NGF; GRIA1;	GO:0050804~modulation of chemical synaptic transmission	4	71	5.63380281690141	0.0178020887996497	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	LAMC1; TMEFF1; BARX1;	GO:0009888~tissue development	3	39	7.69230769230769	0.0181998194335337	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	IGFBP3; RGS22; DDIT4L;	GO:0009968~negative regulation of signal transduction	3	39	7.69230769230769	0.0181998194335337	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	AGT; APOE; UCHL1;	GO:0043407~negative regulation of MAP kinase activity	3	39	7.69230769230769	0.0181998194335337	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	FGF18; FGF2; ANGPT1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	3	39	7.69230769230769	0.0181998194335337	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	GREM1; AGT; NOX4;	GO:0061098~positive regulation of protein tyrosine kinase activity	3	39	7.69230769230769	0.0181998194335337	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	MT1G; MT1H; MT1L;	GO:0071276~cellular response to cadmium ion	3	39	7.69230769230769	0.0181998194335337	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	TRABD2B; WNT2; RSPO4; RSPO1; CPZ; FERMT2; RSPO3;	GO:0016055~Wnt signaling pathway	7	194	3.60824742268041	0.0184356493843388	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	INHBA; CXCL12; COLEC12; NOX4;	GO:0006952~defense response	4	72	5.55555555555556	0.0185992305860969	0.102327515227496	1	1	0.997102327989186	0.997102327989186	0.849148781828196
down	HMGA2; FOXF2; LOXL2;	GO:0001837~epithelial to mesenchymal transition	3	40	7.5	0.0193760129688065	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	DDR2; ROS1; EPHA5; PDGFRA;	GO:0033674~positive regulation of kinase activity	4	73	5.47945205479452	0.0194181620410443	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	CACNA2D1; CACNG7; CCL8; TRPC4;	GO:0006816~calcium ion transport	4	74	5.40540540540541	0.0202590298138878	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
up	CYP2F1; CYP2C19; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	4	21	19.047619047619	0.0204344323122087	0.410163295998662	1	1	0.99999992997781	0.99999992997781	1
down	GIP; ISL1; NKX6-1;	GO:0032024~positive regulation of insulin secretion	3	42	7.14285714285714	0.0218516141569736	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	APOE; GPX8; CYGB; PXDN;	GO:0098869~cellular oxidant detoxification	4	77	5.19480519480519	0.0229146013822537	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	MMP2; COL15A1; MMP23B;	GO:0030574~collagen catabolic process	3	43	6.97674418604651	0.0231510718802626	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
up	CXCL14; SAA2; SAA1; CCR5; CXCR3; CCR2; DEFB4A; HMGB1P1;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.023744267019193	0.447175820060512	1	1	0.99999992997781	0.99999992997781	1
up	GCNT3; MUC5AC; MUC21; MUC6; B3GNT6; MUC15; MUC13;	GO:0016266~O-glycan processing	7	60	11.6666666666667	0.0239064569686047	0.447175820060512	1	1	0.99999992997781	0.99999992997781	1
up	APOA1; APOA4; ABCA12;	GO:0033700~phospholipid efflux	3	12	25	0.0240319178817696	0.447175820060512	1	1	0.99999992997781	0.99999992997781	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0240319178817696	0.447175820060512	1	1	0.99999992997781	0.99999992997781	1
down	CLEC3B; COL1A2; COMP;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.0244916256185252	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	GREM1; HAND2; TWIST1;	GO:0045668~negative regulation of osteoblast differentiation	3	44	6.81818181818182	0.0244916256185252	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	FGF10; HAND2; SIX1;	GO:0048538~thymus development	3	44	6.81818181818182	0.0244916256185252	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	AGT; COL1A1; SCX; PIEZO2;	GO:0071260~cellular response to mechanical stimulus	4	79	5.06329113924051	0.0247970050685766	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	FBLN1; ANGPT1; ARHGDIG;	GO:0007162~negative regulation of cell adhesion	3	45	6.66666666666667	0.0258732385695855	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	GIP; NFATC4; SHANK1;	GO:0060291~long-term synaptic potentiation	3	45	6.66666666666667	0.0258732385695855	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	GLI2; CCL2; FOXF1;	GO:0071407~cellular response to organic cyclic compound	3	45	6.66666666666667	0.0258732385695855	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
down	DDR2; EPHA5; NGF; PDGFRA; ROS1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	5	120	4.16666666666667	0.0259653640304733	0.104091789344267	1	1	0.997102327989186	0.997102327989186	0.863789332942305
up	RAET1L; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0268396876662392	0.488381980244559	1	1	0.99999992997781	0.99999992997781	1
down	SIX1; C1QTNF5; CYTL1;	GO:0048839~inner ear development	3	46	6.52173913043478	0.0272958507727193	0.107608642469374	1	1	0.997102327989186	0.997102327989186	0.892973385153618
down	FGF10; AGT; IGF1; FGF2; SBK2;	GO:0000187~activation of MAPK activity	5	122	4.0983606557377	0.0275570717116773	0.108448859877543	1	1	0.997102327989186	0.997102327989186	0.899945797090245
up	PRSS38; ADAMDEC1; KLK10; KLK8; HP; HPR; LTF; CFI; CTSG; MMP7; CPA3; GZMH; KEL; MMP12; KLK7; TMPRSS3; HABP2; MMEL1; PM20D1; TMPRSS11A; KLK12; KLK13; KLK5; TPSAB1; CPA6; TPSB2; PGA3; PGC; TPSD1;	GO:0006508~proteolysis	29	436	6.65137614678899	0.0281309613255161	0.507138719451665	1	1	0.99999992997781	0.99999992997781	1
up	S100A8; HP; HPR;	GO:0002526~acute inflammatory response	3	13	23.0769230769231	0.0286579664860263	0.507246006802665	1	1	0.99999992997781	0.99999992997781	1
up	JCHAIN; IGKV3-20; IGHA2;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.0286579664860263	0.507246006802665	1	1	0.99999992997781	0.99999992997781	1
down	LAMA4; FOXC2; ADAMTS5;	GO:0120163~negative regulation of cold-induced thermogenesis	3	47	6.38297872340426	0.0287593799512802	0.11123911113231	1	1	0.997102327989186	0.997102327989186	0.923100258025922
down	KCNK2; GIP; ITGA8; NGF;	GO:0007613~memory	4	83	4.81927710843374	0.0288343596910143	0.111338152574037	1	1	0.997102327989186	0.997102327989186	0.92392213784393
down	GREM1; SLIT3; AGT; INHBA; NPPB;	GO:0030308~negative regulation of cell growth	5	124	4.03225806451613	0.0292094426523148	0.112593663557214	1	1	0.997102327989186	0.997102327989186	0.934340798157987
down	AR; COMP; EN1; ETNK2;	GO:0035264~multicellular organism growth	4	84	4.76190476190476	0.0299009681917605	0.11486658138402	1	1	0.997102327989186	0.997102327989186	0.953202249054527
down	KCNU1; KCNK2; HPN; KCNJ8; KCNK9;	GO:0071805~potassium ion transmembrane transport	5	125	4	0.0300585606714816	0.115275602575155	1	1	0.997102327989186	0.997102327989186	0.956596447041468
down	EN1; CDK5R2; FAIM2;	GO:0021549~cerebellum development	3	48	6.25	0.0302637223337526	0.115865354605454	1	1	0.997102327989186	0.997102327989186	0.961490411455591
down	ROS1; SBK2; NRK;	GO:0023014~signal transduction by protein phosphorylation	3	49	6.12244897959184	0.0318087534531157	0.119521250417443	1	1	0.997102327989186	0.997102327989186	0.991828287522842
up	F13A1; IL2RA; IGHG4; SAA1; CD80; IL13; FLT3; CCR2; FASLG; RORC; CCR5; IL5RA; IRF4; BATF; IL1F10; CCL19; IL36B; IL36G; IL36RN; IL20RA;	GO:0019221~cytokine-mediated signaling pathway	20	278	7.19424460431655	0.0319417490726353	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	CYP2C9; UGT1A1; CYP2C19; UGT1A7;	GO:0017144~drug metabolic process	4	25	16	0.0335644149527117	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	CYP2C9; CYP2C19; CYP2F1; CYP2C18;	GO:0042738~exogenous drug catabolic process	4	25	16	0.0335644149527117	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	CTAGE4; CTAGE8; CTAGE6;	GO:0035459~vesicle cargo loading	3	14	21.4285714285714	0.0337194652570096	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	P2RY10; GPR171; P2RY13;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	3	14	21.4285714285714	0.0337194652570096	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	ADRA2A; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	3	14	21.4285714285714	0.0337194652570096	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0337194652570096	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
down	EN1; NPAS4; SHANK1;	GO:0035176~social behavior	3	51	5.88235294117647	0.0350202852209691	0.119521250417443	1	1	0.997102327989186	0.997102327989186	0.991828287522842
down	COMP; HSPB2; HSPB7;	GO:0006986~response to unfolded protein	3	52	5.76923076923077	0.0366864403825711	0.119521250417443	1	1	0.997102327989186	0.997102327989186	0.991828287522842
down	INHA; INHBA; LHCGR; SOX8;	GO:0008584~male gonad development	4	90	4.44444444444444	0.0367863160594191	0.119521250417443	1	1	0.997102327989186	0.997102327989186	0.991828287522842
up	CD40LG; IRF8; SCIMP; CCL19;	GO:0032735~positive regulation of interleukin-12 production	4	26	15.3846153846154	0.0374605531621759	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
down	GREM1; APOE; IGFBP4; ISL1; SFRP4; CTHRC1;	GO:0090090~negative regulation of canonical Wnt signaling pathway	6	179	3.35195530726257	0.0377176816240701	0.119521250417443	1	1	0.997102327989186	0.997102327989186	0.991828287522842
down	UCHL1; BVES; FAIM2;	GO:0002931~response to ischemia	3	53	5.66037735849057	0.0383925947700103	0.119521250417443	1	1	0.997102327989186	0.997102327989186	0.991828287522842
up	CIDEA; FCGR2B; FFAR4;	GO:0050710~negative regulation of cytokine secretion	3	15	20	0.0392112497928497	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	TYROBP; MNDA; CCR2; CCR5; TRAT1; LILRB2;	GO:0006968~cellular defense response	6	53	11.3207547169811	0.0394837448462519	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
down	PENK; SOD3; GPX8; NOX4;	GO:0034599~cellular response to oxidative stress	4	94	4.25531914893617	0.0418415829878735	0.126140066360501	1	1	0.997102327989186	0.997102327989186	1
down	SLC22A31; SLC1A7; TRPA1; SLC5A12;	GO:0006811~ion transport	4	96	4.16666666666667	0.0445090033950395	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
down	CCL2; CCL8; CCL7; CCL11;	GO:0071346~cellular response to interferon-gamma	4	96	4.16666666666667	0.0445090033950395	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
up	ADRA2A; EDN3; ACE2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.0451260815845445	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
down	NGF; IGF1; PDGFRA;	GO:0048015~phosphatidylinositol-mediated signaling	3	57	5.26315789473684	0.0456126313754107	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
down	IGF1; ELANE; RBPMS2;	GO:0048661~positive regulation of smooth muscle cell proliferation	3	57	5.26315789473684	0.0456126313754107	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
down	ADRB3; MFAP2; EBF2; FGF21;	GO:0120162~positive regulation of cold-induced thermogenesis	4	97	4.12371134020619	0.0458776258778253	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
up	APOA4; SELE; CD40LG; CD209;	GO:0007159~leukocyte cell-cell adhesion	4	28	14.2857142857143	0.0459979862260465	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	FOXE1; KRT17; TGM3; FOXQ1;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.0459979862260465	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	FOXN1; NCKAP1L; GPR174; SIT1;	GO:0043029~T cell homeostasis	4	28	14.2857142857143	0.0459979862260465	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
up	S100A8; S100A9; CTSG; S100A12;	GO:0050832~defense response to fungus	4	28	14.2857142857143	0.0459979862260465	0.518168550064293	1	1	0.99999992997781	0.99999992997781	1
down	COL1A1; COL11A1; ATP6V1B1; SIX1; MYO7B;	GO:0007605~sensory perception of sound	5	143	3.4965034965035	0.0480240198742008	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
down	FGF10; COL1A1; RSPO1; SFRP4; RSPO3;	GO:0090263~positive regulation of canonical Wnt signaling pathway	5	144	3.47222222222222	0.0491735503493917	0.130053318363205	1	1	0.997102327989186	0.997102327989186	1
